| [1] |
杨娜，李维勤. 慢重症新诊断标准及治疗进展[J/CD]. 中华危重症医学杂志（电子版），2016，9（3）：197-200.
|
| [2] |
Kramer CL. Intensive care unit-acquired weakness[J]. Neurol Clin, 2017, 35 (4): 723.
|
| [3] |
Bierbrauer J, Koch S, Olbricht C, et al. Early type Ⅱ fiber atrophy in intensive care unit patients with nonexcitable muscle membrane[J]. Crit Care Med, 2012, 40 (2): 647-650.
|
| [4] |
Kraner SD, Novak KR, Wang Q, et al. Altered sodium channel-protein associations in critical illness myopathy[J]. Skelet Muscle, 2012, 2 (1): 17.
|
| [5] |
Koesters A, Engisch KL, Rich MM. Decreased cardiac excitability secondary to reduction of sodium current may be a significant contributor to reduced contractility in a rat model of sepsis[J]. Crit Care, 2014, 18 (2): R54.
|
| [6] |
Nardelli P, Vincent JA, Powers R, et al. Reduced motor neuron excitability is an important contributor to weakness in a rat model of sepsis[J]. Exp Neurol, 2016 (282): 1-8.
|
| [7] |
Friedrich O, Reid MB, van den Berghe G, et al. The sick and the weak: neuropathies/myopathies in the critically ill[J]. Physiol Rev, 2015, 95 (3): 1025-1109.
|
| [8] |
Guillouet M, Gueret G, Rannou F, et al. Tumor nec-rosis factor-alpha downregulates sodium current in skeletal muscle by protein kinase C activation: involvement in critical illness polyneuromyopathy[J]. Am J Physiol Cell Physiol, 2011, 301 (5): C1057-C1063.
|
| [9] |
Llano-Diez M, Cheng A J, Jonsson W, et al. Impaired Ca2+ release contributes to muscle weakness in a rat model of critical illness myopathy[J]. Crit Care, 2016, 20 (1): 254.
|
| [10] |
Kraner SD, Wang Q, Novak KR, et al. Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy[J]. Am J Physiol Reg I, 2011, 300 (6): R1384-R1391.
|
| [11] |
Zink W, Kaess M, Hofer S, et al. Alterations in in-tracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis[J]. Crit Care Med, 2008, 36 (5): 1559-1563.
|
| [12] |
Friedrich O, Yi B, Edwards JN, et al. IL-1α reversi-bly inhibits skeletal muscle ryanodine receptor. A novel mechanism for critical illness myopathy?[J]. Am J Resp Cell Mol, 2014, 50 (6): 1096-1106.
|
| [13] |
刘雪云，李高权，徐守宇. 废用性肌萎缩的蛋白质合成和降解途径[J]. 中国运动医学杂志，2013，32（7）：654-657.
|
| [14] |
Sacheck JM, Hyatt JK, Raffaello A, et al. Rapid dis-use and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases[J]. Faseb J, 2007, 21 (1): 140-155.
|
| [15] |
Dupont-Versteegden EE, Strotman BA, Gurley CM, et al. Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei[J]. Am J Physiol Regul Integr Comp Physiol, 2006, 291 (6): R1730-R1740.
|
| [16] |
Hu NF, Chang H, Du B, et al. Tetramethylpyrazine ameliorated disuse-induced gastrocnemius muscle atrophy in hindlimb unloading rats through suppression of Ca2+/ROS-mediated apoptosis[J]. Appl Physiol Nutr Metab, 2017, 42 (2): 117-127.
|
| [17] |
Wan J, Chen D, Yu B, et al. Leucine protects against skeletal muscle atrophy in lipopolysaccharide-challenged rats[J]. J Med Food, 2017, 20 (1): 93-101.
|
| [18] |
Belova SP, Shenkman BS, Kostrominova TY, et al. Paradoxical effect of IKK inhibition on the expression of E3 ubiquitin ligases and unloading-induced skeletal muscle atrophy[J]. Physiol Rep, 2017, 5 (16): e13291.
|
| [19] |
屈惠莹，包翠芬，于迪，等. 地塞米松诱导的危重病性肌病大鼠骨骼肌Beclin1、LC3的表达[J]. 中国临床解剖学杂志，2017（3）：276-281.
|
| [20] |
Banduseela VC, Chen YW, Kultima HG, et al. Impa-ired autophagy, chaperone expression, and protein synthesis in response to critical illness interventions in porcine skeletal muscle[J]. Physiol Genomics, 2013, 45 (12): 477-486.
|
| [21] |
Kang C, Yeo D, Ji LL. Muscle immobilization activates mitophagy and disrupts mitochondrial dynamics in mice[J]. Acta Physiol (Oxf), 2016, 218 (3): 188-197.
|
| [22] |
Han B, Tong J, Zhu MJ, et al. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway[J]. Mol Reprod Dev, 2008, 75 (5): 810-817.
|
| [23] |
Bloch SA, Lee JY, Wort SJ, et al. Sustained elevation of circulating growth and differentiation factor-15 and a dynamic imbalance in mediators of muscle homeostasis are associated with the development of acute muscle wasting following cardiac surgery[J]. Crit Care Med, 2013, 41 (4): 982-989.
|
| [24] |
Bloch SA, Lee JY, Syburra T, et al. Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs[J]. Thorax, 2015, 70 (3): 219-228.
|
| [25] |
孙文武，毛恩强. 微循环变化对于脓毒症患者液体复苏治疗的意义[J/CD]. 中华危重症医学杂志（电子版），2016，9（3）：201-204.
|
| [26] |
Pollock N, Staunton CA, Vasilaki A, et al. Denervated muscle fibers induce mitochondrial peroxide generation in neighboring innervated fibers: role in muscle aging[J]. Free Radica Biol Med, 2017 (112): 84-92.
|
| [27] |
Wagatsuma A, Kotake N, Mabuchi K, et al. Express-ion of nuclear-encoded genes involved in mitochondrial biogenesis and dynamics in experimentally denervated muscle[J]. J Physiol Biochem, 2011, 67 (3): 359-370.
|
| [28] |
Tavi P, Westerblad H. The role of in vivo Ca2+ signals acting on Ca2+-calmodulin-dependent proteins for skeletal muscle plasticity[J]. J Physiol, 2011, 589 (21): 5021-5031.
|
| [29] |
Kalamgi RC, Salah H, Gastaldello S, et al. Mechano-signalling pathways in an experimental intensive critical illness myopathy model[J]. J Physiol, 2016, 594 (15): 4371-4388.
|
| [30] |
Rocheteau P, Chatre L, Briand D, et al. Sepsis indu-ces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy[J]. Nat Commun, 2015, 6 (24): 10145.
|
| [31] |
Derde S, Vanhorebeek I, Ververs E, et al. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits[J]. Crit Care Med, 2010, 38 (2): 602-611.
|
| [32] |
Weber-Carstens S, Schneider J, Wollersheim T, et al. Critical illness myopathy and GLUT4[J]. Am J Resp Crit Care, 2013, 187 (4): 387-396.
|
| [33] |
Ono Y, Sakamoto K. Lipopolysaccharide inhibits myo-genic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-kappaB signaling pathway and myoblast-derived tumor necrosis factor-alpha[J]. PLoS One, 2017, 12 (7): e182040.
|
| [34] |
Munoz-Canoves P, Scheele C, Pedersen BK, et al. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?[J]. Febs J, 2013, 280 (17): 4131-4148.
|
| [35] |
Stasko SA, Hardin BJ, Smith JD, et al. TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle[J]. J Appl Physiol, 2013, 114 (11): 1629-1636.
|
| [36] |
Janssen SP, Gayan-Ramirez G, van den Bergh A, et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats[J]. Circulation, 2005, 111 (8): 996-1005.
|
| [37] |
Wieske L, Witteveen E, Petzold A, et al. Neurofilame-nts as a plasma biomarker for ICU-acquired weakness: an observational pilot study[J]. Crit Care, 2014, 18 (1): R18.
|
| [38] |
Price DR, Mikkelsen ME, Umscheid CA, et al. Neuro-muscular blocking agents and neuromuscular dysfunction acquired in critical illness: a systematic review and meta-analysis[J]. Crit Care Med, 2016, 44 (11): 2070-2078.
|
| [39] |
Nardelli P, Vincent JA, Powers R, et al. Reduced motor neuron excitability is an important contributor to weakness in a rat model of sepsis[J]. Exp Neurol, 2016 (282): 1-8.
|
| [40] |
Miura A, Hino H, Uchida K, et al. Peripheral nerve conduction abnormalities precede morphological alterations in an experimental rat model of sepsis[J]. J Anesth, 2016, 30 (6): 961-969.
|
| [41] |
Aare S, Radell P, Eriksson LI, et al. Role of sepsis i-n the development of limb muscle weakness in a porcine intensive care unit model[J]. Physiol Genomics, 2012, 44 (18): 865-877.
|
| [42] |
Feng L, Liu X, Cao F, et al. Anti-stress effects of ginseng total saponins on hindlimb-unloaded rats assessed by a metabolomics study[J]. J Ethnopharmacol, 2016 (188): 39-47.
|